TAHP Medical + Pharmacy Directors Forum
These invitation-only events offer our health plan Medical and Pharmacy Directors the unique opportunity to interface with their peers and hear from state and national experts as they discuss common challenges and best practices. If you are interested in sponsoring and presenting at this forum email firstname.lastname@example.org for more information. This meeting is only open to our health plan MDs & PharmDs.
Hampton Inn 200 San Jacinto Blvd, Austin, TX
Oct 24, 2023
9:00 am - 3:30 pm
9:00 - 9:45am
The Healthy Equity and Cost Benefits of Immunoglobulin Infusions at Home
Immunoglobulins, derived from donated human plasma, are used in the treatment of hundreds of disease states, including immunodeficiencies and autoimmune disorders. This presentation will cover the use of immunoglobulin (Ig) therapy in these various conditions, as well as the importance of the clinician’s role in the individualization of care and Ig treatment planning. Topics will include strategies for cost containment and the health equity benefits of home infusion as a site of care.
- James Sheets, CEO, CSI Pharmacy
- Ed O’Bryan, CMO, CSI Pharmacy
9:50 - 10:35am
How Virtual Health Engagement drives successful P4Q and NMDOH
Pay For Quality and Non-Medical Drivers are Health are among the top 2 priorities for Texas Medicaid in 2024 and beyond. During this talk, you will learn how the right virtual health engagement strategy improves health outcomes, leading to over performing on P4Q and NMDOH.
- Shameet Luhar, CEO, Vheda Health
10:40 - 11:25am
Patient journey to an approved Alzheimer’s disease treatment for patients with Early Alzheimer’s Disease
Alzheimer’s disease (AD) is a growing public health crisis and represents a crucial unmet need in healthcare. New AD diagnostic tools and therapies are evolving the management of AD, changing the patient journey towards earlier identification and treatment initiation.
During this program, we will overview the patient journey to treatment with a therapy and discuss signs and diagnosis of early AD, the clinical trial data in informing selection for treatment for appropriate patients, key considerations for initiating the treatment, monitoring for safety, and economic impact of early intervention.
- Angelo DeLuca, PharmD, Director, HEOR at Eisai Inc
11:30 - 12:15pm
12:15 - 1:05pm
MDI Health Technologies - Presentation
More Agenda Item Coming Soon!
James Sheets, PharmD
CEO, CSI Pharmacy
James L. Sheets is the CEO and founder of CSI Pharmacy. He has a passion for developing clinical programs that add value to the homecare provided for infusion patients. He earned his Doctor of Pharmacy degree from the University of Arkansas for Medical Sciences, College of Pharmacy. His pharmacy experience includes practice in community, hospital, nuclear, compounding, and the home infusion settings. Dr. Sheets has over 20 years’ experience working with immunoglobulin (Ig) therapy and administration in the home. He is an active member of NASP, NHIA, and IgNS. He contributes as a member on the Immunoglobulin standards of care and leadership committees for the Immune Globulin National Society (IgNS). He serves as an advisory board member for Octapharma, Evolve Biologics & KORU Medical, as well as on the medical advisory board for the MG Hope Foundation. He is passionate that all patient’s therapies should be individualized to meet their specific needs. James enjoys sharing knowledge and helping others through presentations at local patient support groups. He frequently speaks at local Myositis KIT meetings and Myasthenia Gravis patient meetings in the various regions across the nation. He often remarks that the people he meets at these groups are truly inspirational and motivate him to grow and improve as a person.×
Edward O’Bryan, MD, MBA, CPE
CMO, CSI Pharmacy
Ed has a 15-year history of successfully integrating clinical quality initiatives, digital innovations, health information technology, cost-containment strategies and logistics into health systems, physician practices, startups, pharmacies, businesses and nonprofits to improve patient and financial outcomes and encourage positive change. He received his M.D. from the Medical University of South Carolina where he spent the majority of his clinical career in the ER, and his M.B.A. from the University of Tennessee. His passions are health equity and value creation for challenging patient populations. Ed is now Chief Medical Officer for Graham Healthcare and CSI Pharmacy, and is the co-founder of OneWorld Health and the For Others Foundation.×
CEO, Vheda Health
Shameet Luhar brings nearly 2 decades of experience leading and growing payor-focused technology companies. As the grandson and son of two generations of physicians, enabling access to care has been a cornerstone focus of his career. Shameet currently serves as CEO of Vheda Health, a virtual health engagement company dedicated to accelerating health equity for everyone by providing simple access to care from anywhere.
Under Shameet’s leadership, Vheda Health has transformed itself into an industry leader, partnering with the nation’s largest government payors, consistently delivering a 3:1 ROI and
average 20% medical savings by inspiring action in underserved populations.
Prior to Vheda Health, Shameet held senior roles at Anthem, CareFirst BCBS, and Deloitte. Shameet was an early member of Resolution Health, a data analytics company purchased by Anthem. There Shameet was responsible for deploying member care management programsfor Anthem’s 33 million Commercial and Medicare members. Shameet’s work on the Medicare STARS Outbound Call program was recognized by URAC with a 2013 Gold Medal.
Shameet holds an MS in Medical Informatics from Northwestern University and BS inInformation Systems and Supply Chain Management from the University of Maryland – College Park.×
Angelo DeLuca, PharmD
Director, HEOR at Eisai Inc
Angelo has more than 18 years of experience in health-system pharmacy administration and the pharmaceutical industry. He graduated with as a Doctor of Pharmacy from the University of the Sciences in Philadelphia.×